Richard Paul Russo Jr - Oct 6, 2022 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
CEO and President
Signature
/s/ Rich Russo
Stock symbol
BNKL
Transactions as of
Oct 6, 2022
Transactions value $
$0
Form type
4
Date filed
10/13/2022, 01:17 PM
Previous filing
Oct 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNKL Employee Stock Option (right to buy) Award $0 +60K $0.00 60K Oct 6, 2022 Common Stock, par value $0.001 60K $0.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 1/3 on each of the first three anniversaries of the grant date.